Dr. Tekwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9911 Kennerly Rd
Saint Louis, MO 63128Phone+1 314-842-2020Fax+1 314-842-1407
Summary
- Navin Tekwani, MD is an Ophthalmologist based in Saint Louis, MO, with subspecialties in Cataract Related and Retinal Disease. He completed his education at the University of Missouri Kansas City School of Medicine with residency in ophthalmology. Dr. Tekwani has extensive experience in cornea/external disease, general/comprehensive ophthalmology, and cataract and anterior segment conditions. His research has been published in numerous well-regarded journals including the American Journal of Ophthalmology and Journal of Refractive Surgery. He has been involved in clinical trials focused on treating Dry Eye Disease and Postsurgical Inflammation. Dr. Tekwani is also a recognized Fellow of the American Academy of Ophthalmology.
Education & Training
University of Missouri-Kansas City School of MedicineResidency, Ophthalmology, 1998 - 2001
Louis A Weiss Memorial HospitalInternship, Transitional Year, 1997 - 1998- University of Missouri Kansas City School of MedicineClass of 1997
Certifications & Licensure
MO State Medical License 1998 - 2025
OH State Medical License 2001 - 2003- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation Start of enrollment: 2014 May 01
- Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 48 citationsNetarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 TrialSanjay Asrani, Alan L. Robin, Janet B. Serle, Richard A Lewis, Dale W Usner
American Journal of Ophthalmology. 2019-11-01 - 40 citationsRisk factors for intraoperative epithelial defect in laser in-situ keratomileusis.Navin H Tekwani, David Huang
American Journal of Ophthalmology. 2002-09-01 - 8 citationsSecondary microkeratome-induced flap interference with the pathway of the primary flapNavin H Tekwani, Maria Regina Chalita, Ronald R Krueger
Ophthalmology. 2003-07-01
Press Mentions
New ASCs in 2020: A State-by-State BreakdownDecember 17th, 2020- Dr. Navin Tekwani Clears Hurdle for New Eye ASC — 5 Things to KnowSeptember 9th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
